Independent health informationUrgent helpHow information is checked
Evidence Health
Menu
Health guide

How Long Does Citalopram Take to Work? A Realistic Check-In Guide

Patient and clinician reviewing progress notes during a follow-up visit
Original editorial image.

Regional scope: United States. Testing, treatment and urgent-care routes can differ by country; use local services and prescribing advice.

Written byEvidence Health Editorial Team
Evidence checked2026-10-05
References3 sources
UpdatedOctober 5, 2026
On this page

Quick timeline

  • Some people notice sleep, appetite, or anxiety changes before mood improves.
  • Antidepressant benefit commonly builds over several weeks; the prescriber should set an individual review point.
  • No change in the first few days does not prove failure, and early side effects do not prove the drug will not help.
  • Worsening mood, self-harm thoughts, severe agitation, or mania-like symptoms need prompt contact—not a wait-and-see rule.
  • Do not change dose or stop suddenly without the prescriber’s plan.

Citalopram does not work like a pain reliever with an immediate, obvious effect. A person may notice changes in sleep, appetite, or anxiety before a broader change in depression, and the timeline varies. The useful question is not “Should I feel fixed by day seven?” but “What should I watch, when will we review progress, and what symptoms mean I should call sooner?”

What “working” can mean in the first weeks

Depression can affect mood, energy, concentration, sleep, appetite, and the ability to manage ordinary tasks. Improvement may show up in one area before another. Someone may sleep a little more regularly while motivation remains low, or feel less physical anxiety without yet feeling cheerful. Keep expectations grounded: treatment is a process, not a guaranteed switch.

Early side effects can overlap with depression symptoms. Nausea, restlessness, fatigue, or sleep changes may appear after starting or changing treatment. That overlap can make the first days confusing. A short daily note—mood, sleep, functioning, side effects, and missed doses—can help the clinician judge trend rather than relying on memory at a later appointment.

A practical check-in timeline

Period What may be useful to notice What to do
First days How you tolerate it, sleep, nausea, unusual agitation, safety Follow label; report severe or concerning changes promptly.
Early weeks Gradual shifts in routine, anxiety, interest, concentration, or side effects Keep notes and attend the planned follow-up.
Several weeks and beyond Whether symptoms and daily function are meaningfully improving Review benefits, burden, and next steps with prescriber.
Any time Self-harm thoughts, severe confusion/agitation, fainting, allergic reaction Urgent help; do not wait for the scheduled review.

The exact interval for follow-up depends on symptoms, safety, age, other conditions, and clinical judgment. If no review was scheduled, ask the clinic when to check in. Don’t interpret a generic timeline online as a deadline for changing treatment.

Why “give it more time” can be incomplete advice

Some online answers tell everyone to wait a fixed number of weeks. That can be harmful if a person is deteriorating, experiencing a serious adverse effect, or feeling unsafe. Other posts treat any uncomfortable first-day symptom as proof that the medicine is wrong. Both oversimplify. A mild, manageable symptom with no deterioration can be monitored with the care team; self-harm thoughts or severe agitation call for urgent help regardless of how long treatment has been underway.

For people under 25 and other higher-risk situations, closer monitoring after starting or changing an antidepressant may be advised. Tell a trusted person what warning signs to look for if that is part of the clinical plan. If you may act on suicidal thoughts, call emergency services or 988 in the US now.

Factors that can make progress harder to interpret

  • Missed or inconsistent doses: they may affect tolerability and make it difficult to judge the treatment.
  • Other medicines: interactions or side effects from a new drug can mimic worsening anxiety or fatigue.
  • Sleep, alcohol, and substances: each can change mood and concentration independently.
  • Underlying conditions: thyroid problems, chronic pain, anemia, and other illnesses may contribute to similar symptoms.
  • Life events: improvement can occur while stress is still present; treatment is not a guarantee that circumstances change.

Share changes honestly, including supplements and substances. Clinicians need the full context to decide whether to continue, adjust, or reconsider the treatment plan.

When to ask for a treatment review

Contact the prescriber if side effects are making you consider stopping, if you have missed multiple doses, if symptoms are getting worse, or if there is little meaningful progress by the review point. Ask what “enough improvement” means for you—perhaps getting out of bed more reliably, returning to work, or fewer panic symptoms—not only a score on a questionnaire.

Do not raise the amount, take someone else’s medication, or add a supplement marketed for mood without checking first. Citalopram has interaction and heart-rhythm considerations. Abrupt stopping can cause withdrawal symptoms and may complicate assessment of whether depression is returning.

Questions to take to the appointment

  1. When should we review my symptoms and side effects?
  2. Which changes are expected, and which mean I should call today?
  3. What should I do if I miss a dose or cannot refill on time?
  4. How will we tell a side effect from the condition itself?
  5. If we decide to stop or change treatment, what is the safe plan?

Related reading: citalopram side effects and warning signs, weight and discontinuation questions, and mental-health and sleep resources.

General education only—not a personal prediction of response. Keep follow-up with the prescriber and seek immediate help for safety concerns.

Progress is more than a mood score

For some people, an early sign of progress is answering a message, showering regularly, finishing a meal, or getting through a work shift. For someone else, it may be fewer panic episodes or less time stuck in rumination. These small functional changes do not prove the treatment is successful, but they give a richer picture than asking only whether you feel happy. Track what matters in your day-to-day life and share it during follow-up.

Also note setbacks. Depression can fluctuate with sleep, grief, illness, and stress. One bad day does not erase a trend, but a serious decline should not be dismissed as normal fluctuation. If the path is unclear, ask the clinician how they will measure response and what alternative explanations should be considered.

Keep the plan accessible between visits

If you cannot reach the prescriber, ask the clinic who covers urgent medication questions and whether a pharmacist can review the label. Refill gaps should be addressed before tablets run out; abrupt interruption can create confusing symptoms. If you have stopped because of a reaction, explain what happened and when the last dose was rather than restarting at a different amount without advice.

People often compare progress with a friend who takes the same medicine. The diagnoses, dose, health history, and other supports may be different. Use someone else’s story for empathy, not as a benchmark or a reason to change your own plan.

How clinicians think about a partial response

At follow-up, a clinician may ask about symptom severity, daily functioning, side effects, adherence, stressors, and safety. They may use a brief questionnaire, but the score should be interpreted alongside your experience. Partial improvement can still matter; it may lead to more time, psychotherapy, a diagnostic review, or a different treatment plan. A lack of change may also prompt a check for missed doses, interactions, sleep disorders, substance use, or another medical cause.

Do not compare your timeline with a friend’s or an online poster’s. Age, diagnosis, symptom duration, other conditions, previous treatment, and support all vary. If you have a history of mania or unusually elevated energy with little need for sleep, tell the prescriber; antidepressant decisions can differ in that context.

Make the follow-up actionable by asking for a dated checkpoint and a plan for the time between now and then. You should know how to report worsening symptoms, who covers urgent calls, and what happens if the current approach is not helping enough.

Do not wait silently through worsening symptoms

Online advice to wait several weeks can be misapplied. A planned timeline is for reassessing benefit when symptoms are stable enough—not permission to ignore deterioration. Contact the prescriber sooner if depression is worsening, anxiety becomes unmanageable, you cannot function, or side effects are severe. Tell a trusted person if you have safety concerns and make a plan for how to reach help.

If you have thoughts of suicide or self-harm, call or text 988 in the US, go to an emergency department, or call emergency services if danger is immediate. Do not stay alone if you may act on the thoughts. A medication follow-up is important, but crisis care should not wait for a routine appointment or an online reply.

Plan for missed doses and refill delays

Try to request refills before the supply is nearly gone. If insurance, travel, or pharmacy availability creates a gap, call the pharmacy or prescriber early; do not ration tablets by taking them every other day unless specifically directed. A sudden interruption can cause physical symptoms and make it harder to judge whether depression is returning.

If you already missed doses, write down how many and when. Ask a pharmacist what to do next rather than doubling the amount. If you have stopped for several days, contact the prescriber before restarting. Seek urgent help for severe mood deterioration or self-harm risk.

If the expected change does not arrive

A missed target date is a reason for review, not proof you have failed treatment. Ask whether the diagnosis, dose consistency, other conditions, or additional therapy should be considered. Do not increase the dose yourself or judge success solely by whether every symptom has disappeared.

Sources